Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study

被引：0
|
作者：
Aziz Zaanan
Juliette Palle
Emilie Soularue
Florence Leroy
Samy Louafi
David Tougeron
Sylvain Manfredi
Pascal Artru
Astrid Pozet
Julien Taieb
机构：
[1] European Georges Pompidou Hospital,Department of Gastroenterology and Digestive Oncology
[2] Assistance Publique-Hôpitaux de Paris,Department of Medical Oncology
[3] Paris Descartes University,Department of Gastroenterology and Digestive Oncology
[4] Sorbonne Paris Cité,Department of Cancer Medicine
[5] Saint Antoine Hospital,Department of Oncology
[6] Assistance Publique-Hôpitaux de Paris,Department of Gastroenterology
[7] Saint-Louis Hospital,Department of Gastroenterology and Digestive Oncology
[8] Assistance Publique-Hôpitaux de Paris,Department of Gastroenterology and Digestive Oncology
[9] Gustave Roussy Institute,Methodology and Quality of Life in Oncology Unit, INSERM UMR 1098
[10] Oncology Federation of Essonne,undefined
[11] Poitiers University Hospital,undefined
[12] Rennes University Hospital,undefined
[13] Jean Mermoz Hospital,undefined
[14] Besançon University Hospital,undefined
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：107 / 112
页数：5
相关论文
共 50 条
  • [21] A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients
    Zhu, Bo
    Wu, Jun-Rong
    Zhou, Xiao-Ping
    MEDICINE, 2015, 94 (34) : e1428
  • [22] Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review
    Wang, Tao
    He, Mingyuan
    Guan, Wei
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [23] REAL-WORLD DATA OF TRIPLET COMBINATION OF PYROTINIB, TRASTUZUMAB, AND CHEMOTHERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER: A MULTICENTER, RETROSPECTIVE STUDY
    Wang, Biyun
    You, Shuhui
    Xie, Yizhao
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    BREAST, 2023, 71 : S52 - S52
  • [24] Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study
    You, Shuhui
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    Xie, Yizhao
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [25] Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
    Li, Yi
    Gong, Chengcheng
    Lu, Qianyi
    Zhou, Zhaochun
    Luo, Ting
    Li, Wei
    Li, Gang
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] Lapatinib and trastuzumab combination shrinks HER2-positive cancer
    Coles, Charlotte
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (04) : 206 - 206
  • [27] Minimum biopsy set for Her-2 evaluation in gastro-esophageal adenocarcinoma
    Grillo, F.
    Mastracci, L.
    Gullo, I.
    Piol, N.
    Molinaro, L.
    Fassan, M.
    Rugge, M.
    Fiocca, R.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 145 - 145
  • [28] Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer
    Taroh Satoh
    Yasushi Omuro
    Yasutsuna Sasaki
    Yasuo Hamamoto
    Narikazu Boku
    Takao Tamura
    Atsushi Ohtsu
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 949 - 955
  • [29] Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer
    Satoh, Taroh
    Omuro, Yasushi
    Sasaki, Yasutsuna
    Hamamoto, Yasuo
    Boku, Narikazu
    Tamura, Takao
    Ohtsu, Atsushi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 949 - 955
  • [30] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
12345